Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levoxiracetam for cognitive impairment after traumatic brain injury
ChiCTR2300076710Phase 3Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levoxiracetam in traumatic brain injury (TBI) (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: LOTCA score. Started Jul 2020; status: recruiting.
02
Drugs
levoxiracetam
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2300076710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076710.